Nucleotide Market Set to Surge to US$ 1.61 Billion By 2032, Driven by Continuous Advancements in …
The emergence of automated, high-throughput nucleotide synthesis platforms and CRISPR-Cas9 gene editing technologies is significantly speeding up both research and commercial applications. These advancements are fostering innovation and broadening the market's potential, making it easier and faster to develop new products and therapies.